Early Prediction of Gestational Diabetes in High-risk Women Based on Breath Metabolomics
A Cohort Study in Women at High Risk for Gestational Diabetes Based on Breath Metabolomics
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Yifan Fan
- Phone Number: +86 18322337116
- Email: Yvaine_FYF@163.com
Study Locations
-
-
-
Tianjin, China
- Tianjin Central Hospital of Gynecology Obstetrics
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Eligibility Criteria
- 18-55 years old
- 11-14 weeks of pregnancy
- at least one risk factor for GDM
- signed a written informed consent
Exclusion Criteria:
- Diabetes mellitus or abnormal glucose metabolism before pregnancy
- Hyperemesis gravidarum (urine ketone positive))
- Thyroid dysfunction
- Asthmatic patients
- Hypertensive diseases that are difficult to control
- Severe hepatic and renal insufficiency or severe electrolyte disturbance
- Malignant tumor
- Acute inflammation
- lung disease
- Patients with gastritis, duodenum and other digestive system diseases
- Those with upper respiratory or oral problems who cannot cooperate with expiratory collection
- smoker
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
control group
|
|
Gestational Diabetes Group
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Incidence of gestational diabetes mellitus
Time Frame: 24-28 weeks gestation
|
24-28 weeks gestation
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2024KY081
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.